What Is Proviron (Mesterolone)? Complete UK Guide: SHBG, Free Testosterone & Libido (2026)

Proviron (mesterolone) is unique among anabolic steroids: it is simultaneously one of the least anabolic compounds in common use and one of the most pharmacologically interesting. As a DHT-derivative that binds sex-hormone binding globulin (SHBG) with very high affinity, inhibits aromatase activity, and has been used medically for male hypogonadism for decades, it fills a role in steroid cycles that no other single compound replicates. Understanding what Proviron actually does — and what it categorically does not do — is essential for using it intelligently.

What Is Proviron (Mesterolone)?

Mesterolone is a synthetic oral androgen and anabolic steroid derived from dihydrotestosterone (DHT), first developed by Schering in the 1960s. It has remained in clinical use as a pharmaceutical medicine (Proviron) for male hypogonadism and infertility treatment in many European countries, including Germany, where it remains a licensed prescription medicine to this day.

Critically, Proviron is not C-17 alpha-alkylated. Instead, it is 1-methylated, which confers oral bioavailability without the hepatotoxic 17aa modification. This makes Proviron genuinely non-hepatotoxic — an important distinction from most other oral anabolic compounds.

Anabolic:Androgenic Ratio

Mesterolone has an anabolic:androgenic ratio of approximately 100–150:30–40, but this figure significantly understates its androgenic activity at the tissue level and essentially overstates its anabolic utility. In practice, Proviron produces minimal direct anabolic effect and is not used as a mass-building compound. Its pharmacological value is entirely in its ancillary properties.

How Proviron Works: The Key Mechanisms

SHBG Binding: Dramatically Increasing Free Testosterone

This is Proviron's primary performance benefit. Mesterolone has an extraordinarily high affinity for SHBG — significantly higher than testosterone, Masteron, or Turinabol. By binding and occupying SHBG, Proviron frees up testosterone (and other co-administered anabolic steroids) from protein binding, converting bound (inactive) hormone into free (biologically active) hormone. At 50–100 mg/day, this effect is pharmacologically significant and can meaningfully increase the effective anabolic activity of a testosterone base without increasing the actual dose of testosterone.

Aromatase Inhibition

Proviron competitively inhibits aromatase. The degree of aromatase inhibition is weaker than pharmaceutical AIs like Arimidex or Aromasin — Proviron should not replace a pharmaceutical AI in high-testosterone cycles. However, at low testosterone doses (TRT range, 100–200 mg/week), Proviron 50–100 mg/day can provide sufficient aromatase inhibition to control oestrogen without the risk of crashing it with a potent pharmaceutical AI.

Androgen Receptor Activation

Mesterolone activates androgen receptors in muscle tissue, though with relatively low affinity compared to testosterone or Nandrolone. Its androgenic effects are primarily expressed in tissues with high 5-alpha reductase activity (prostate, skin, hair follicles), which explains its usefulness for libido and mood but also its hair loss risk in predisposed men.

Why Proviron Does Not Suppress the HPG Axis (Significantly)

This is Proviron's most unusual property. Despite being an androgen, mesterolone at standard performance doses (50–100 mg/day) produces only mild HPG suppression — significantly less than other anabolic steroids at comparable androgenic doses. The mechanism is not fully established but may relate to its rapid hepatic metabolism and the fact that its primary activity occurs at peripheral tissues rather than centrally at the hypothalamus and pituitary. This is why Proviron has been used in fertility treatment — it does not suppress spermatogenesis as severely as other androgens. It should not be assumed to cause zero suppression — some is still present — but it is meaningfully lower than other AAS.

Performance Applications: When and Why to Use Proviron

Application	Proviron's Role	Dose
Testosterone cycle enhancement	Frees testosterone from SHBG; increases free T bioavailability	50–100 mg/day
Mild oestrogen control at low T doses	Weak aromatase inhibition; replaces or reduces pharmaceutical AI at TRT doses	50–100 mg/day
Libido and sexual function on-cycle	DHT-derived: enhances libido, erectile function, mood, and well-being	25–75 mg/day
Pre-competition hardening	Reduces water retention through oestrogen inhibition; enhances DHT-driven muscle density	50–75 mg/day
Bridge between cycles	Maintains androgen levels without significant HPG suppression	25–50 mg/day

Proviron in PCT: A Common Misconception

Proviron is sometimes suggested for use during PCT as an androgen that maintains libido and well-being while SERMs work to restore HPG axis function. The problem: any androgenic compound during PCT can delay HPG recovery by maintaining androgen receptor activation at the hypothalamic-pituitary level, even at low levels. Proviron's lower suppression does not mean zero suppression. The evidence base for Proviron in PCT is limited. Standard Nolvadex-based PCT without Proviron is the better-evidenced approach. See our complete PCT guide.

Medical Uses

Proviron is licensed in Germany and many European countries for male hypogonadism, specifically in cases where TRT is not appropriate or as an adjunct therapy. It has been used for:

• Partial androgen deficiency: in men with mildly low testosterone and symptoms
• Male infertility: where the cause is androgen deficiency; Proviron improves sperm quality without the full HPG suppression of testosterone therapy
• Depression and mood disorders associated with male hypogonadism

Browse available Proviron products. For TRT context, see our UK TRT complete guide.

Side Effects

Proviron's side effect profile is determined by its DHT-derived androgenic activity:

• Hair loss: Significant risk in genetically predisposed men. Finasteride is not effective (Proviron is already a DHT derivative). This is the most important androgenic concern.
• Acne: Common; manageable with topical treatments and good hygiene.
• Hepatotoxicity: Genuinely minimal — non-17aa structure does not impose significant liver stress. LFTs remain largely unaffected at standard doses.
• Lipid disruption: Modest HDL reduction. Less severe than most other oral androgens.
• HPG suppression: Mild at standard doses, but not zero. PCT considerations apply in longer use.
• Prostate: As a DHT-potent compound, Proviron is contraindicated in men with prostate cancer or significant BPH. Regular PSA monitoring is appropriate in older users.

For full harm reduction protocols, see our safe steroid use guide.

UK Legal Status

Mesterolone is a Class C controlled substance under the Misuse of Drugs Act 1971, despite being a licensed pharmaceutical medicine in other European countries. See our UK steroid law guide.

Frequently Asked Questions

Does Proviron increase testosterone?

Not directly — Proviron does not stimulate testosterone production. It increases free testosterone by displacing testosterone from SHBG, converting bound (inactive) testosterone into free (active) testosterone. This is distinct from increasing total testosterone levels.

Can Proviron replace an AI on cycle?

At testosterone doses below ~200 mg/week, Proviron's aromatase inhibition is often sufficient to control oestrogen without a pharmaceutical AI. At higher testosterone doses (400+ mg/week), Proviron's aromatase inhibition is insufficient and a pharmaceutical AI is required. The two can be used together — Proviron adds SHBG binding and libido benefits while the AI controls residual aromatisation.

Is Proviron suitable for older men on TRT?

Mesterolone has been used in clinical TRT for decades. For older men on TRT experiencing low libido, mood issues, or suboptimal testosterone utilisation despite adequate total testosterone, adding Proviron at 25–50 mg/day may provide benefit. The prostate and PSA monitoring requirement becomes more important with age. Discuss with a TRT specialist.